DURECT Corporation (DRRX) Social Stream
Featured Post From StockTwits About DRRX
$DRRXudupisek, published September 16, 2020
These 2 meetings give a clear understanding of AH data. It is absolutely stunning to see the magical results of 100% survival from the AH study . The totally independent second study done by Dr.McClain in Kentucky showed similar astounding results. Child classification class-3 liver failure are sure to die patients. They survived and went home in 4 days. What else is needed to convince the FDA to approve. The GI guys are begging for this drugs to be available to save lives. My guess is they will get it approved by end of 2021. I expect similar results with Covid once they get a few patients with multiorgan failure. DUR-928 is a unbelievable drug with huge future potential. JB and team did their best to get this company to this stage. Wish it could be faster. But, It is what it is.